IDXG — INTERPACE BIOSCIENCES, INC.
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1054102 ·
Last close
$1.80
Market Cap
$49.86M
52W High
$2.40
52W Low
$1.56
ADV30
6,987
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 9,032,000 | 5,904,000 | 1,123,000 | 721,000 | 33,409,000 | 2,647,000 | 10,327,000 |
| Dec 2025 | 9,224,000 | 6,044,000 | 1,577,000 | 22,657,000 | 33,838,000 | 2,505,000 | 11,476,000 |
| Sep 2025 | 8,756,000 | 5,439,000 | 1,145,000 | 911,000 | 12,036,000 | 1,423,000 | 12,334,000 |
| Jun 2025 | 9,232,000 | 5,276,000 | -468,000 | -640,000 | 12,335,000 | 502,000 | 13,548,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$5,830,000
Investing CF
$-356,000
Financing CF
$-4,431,000
CapEx
$-806,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.77
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-210,805,000
Inventory
$1,114,000
Receivables
$5,649,000
ST Investments
—
EBIT TTM
$3,943,000
Pretax Income TTM
$3,774,000
Interest Exp TTM
$169,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$36,245,000
EBITDA
$4,514,250
Free Cash Flow
$4,635,500
Enterprise Value
$38,823,520
Total Cash
$2,647,000
Total Debt
$0
Shares Out
27,700,904
Trailing EPS
$0.87
Book Value
$1.01
ROE
213.9%
ROA
10.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 38,728,000 | 4,084,000 | 24,575,000 | 33,838,000 | 11,476,000 | — | 5,831,000 |
| Dec 2024 | 46,926,000 | 8,108,000 | 6,702,000 | 14,792,000 | 17,009,000 | — | 4,646,000 |
| Dec 2023 | 40,036,000 | 3,963,000 | 1,954,000 | 13,116,000 | 68,655,000 | — | 3,789,000 |
| Dec 2022 | 31,838,000 | -3,840,000 | -21,958,000 | 15,979,000 | 79,051,000 | — | -7,692,000 |
TTM Snapshot
Revenues TTM
$130,374,000
NetIncome TTM
$-7,698,000
OpCashFlow TTM
$0
Assets (Latest)
$115,906,000
Forward EPS
$-0.15
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BEAT | HeartBeam, Inc. | $49.57M | $0.89 | — |
| BDMD | Baird Medical Investment Holdings Ltd | $48.59M | $1.58 | — |
| AURX | Nuo Therapeutics, Inc. | $47.92M | $0.99 | — |
| SRTS | Sensus Healthcare, Inc. | $52.68M | $3.20 | — |
| COCH | Envoy Medical, Inc. | $53.82M | $0.70 | — |
News headlines (Yahoo Finance, 1h cache)
Interpace Biosciences Announces First Quarter 2026 Financial and Business Results
2026-05-12 20:06 · Yahoo
Interpace Biosciences Announces Fourth Quarter and Full Year 2025 Financial and Business Results
2026-03-30 20:01 · Yahoo
Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure
2026-01-20 14:00 · Yahoo
Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners
2025-12-03 17:12 · Yahoo
Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results
2025-11-12 21:01 · Yahoo
Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting
2025-09-15 13:15 · Yahoo
Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results
2025-08-07 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.